ELI LILLY & Co
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation IN
Business Address LILLY CORPORATE CTR, INDIANAPOLIS, IN, 46285
Mailing Address LILLY CORPORATE CENTER, INDIANAPOLIS, IN, 46285
Phone 3172762000
Fiscal Year End 1231
EIN 350470950
Financial Overview
FY2025 FY
$65.18B
Revenue
$7.27B
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | February 12, 2026 | View on SEC |
| 4/A Insider transaction amendment | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
Annual Reports
10-K February 12, 2026
- Eli Lilly achieved exceptional performance in 2025, driven by robust sales growth, significant profitability, and strategic investments.
- Total revenue reached $50 billion in 2025, a substantial 22.2% increase, primarily driven by product sales.
Insider Trading
STRONG SELL 1 insiders
100 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.